Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Omega-3 Fatty Acids Monotherapy in Alzheimer's Disease and Mild Cognitive Impairment: a Preliminary Randomized Double-Blind Placebo-Controlled Study

NCT00628017 is registered in ClinicalTrials.gov with Taipei City Psychiatric Center, Taiwan as lead sponsor.

NCT NCT00628017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00628017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Omega-3 Fatty Acids Monotherapy in Alzheimer's Disease and Mild Cognitive Impairment: a Preliminary Randomized Double-Blind Placebo-Controlled Study
Lead sponsor
Taipei City Psychiatric Center, Taiwan
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2003
Completion date
March 31, 2005
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, mild cognitive impairment